• LDH Cytotoxicity Assay Kit: Precision Cell Cytotoxicity Meas

  2026-07-07

  Leverage the LDH Cytotoxicity Assay Kit for highly sensitive, non-radioactive cell cytotoxicity measurement in workflows ranging from nanomaterial safety assessment to advanced apoptosis detection. Discover how experimental refinements and insights from magnetic cellulose nanocrystal research deliver robust, reproducible results for translational biomedical studies.

• Berberine Hydrochloride: Advanced Mechanistic Insights for M

  2026-07-07

  Delve into the multifaceted mechanisms of Berberine hydrochloride, including AMPK activation and gut-bone modulation. This article offers a distinct, in-depth perspective on metabolic and osteoimmune research, expanding practical and experimental horizons.

• TIA1-CLSTN1 Splicing Axis Drives EMT and Breast Cancer Metas

  2026-07-06

  This study uncovers how TIA1 suppresses CLSTN1 exon 11 inclusion, thereby inhibiting the epithelial-to-mesenchymal transition (EMT) and metastasis in breast cancer. The research establishes a mechanistic link between alternative splicing, EMT regulation, and tumor cell dissemination, highlighting new therapeutic targets for metastatic breast cancer.

• Gut-Brain Cholinergic Signaling in B. fragilis–Mediated Seiz

  2026-07-06

  Jia et al. reveal that Bacteroides fragilis suppresses seizures via enhanced gut-brain cholinergic signaling, specifically activating colonic ChAT+ cells and vagal pathways. This work establishes a mechanistic foundation for microbiota-targeted therapies in pediatric refractory epilepsy and highlights translational opportunities for research on the acetylcholine neurotransmitter.

• Etoposide (VP-16): Precision in DNA Damage and Cancer Resear

  2026-07-05

  Etoposide (VP-16) delivers targeted DNA double-strand breaks, enabling high-fidelity apoptosis assays and advanced cancer pathway research. Its robust solubility in DMSO and predictable cytotoxicity across diverse cell lines make it a cornerstone for both in vitro and in vivo experimental workflows.

• 1-methyl Adenosine: Unveiling Metabolic Pathways and Biomark

  2026-07-04

  Discover how 1-methyl Adenosine advances RNA modification research and cancer metabolism studies. This article uniquely explores its catabolic fate, analytical quantification, and strategic relevance for biomarker discovery.

• Triamcinolone: Technical Guidance for Glucocorticoid Agonist

  2026-07-03

  Triamcinolone offers a high-purity synthetic glucocorticoid agonist for in vitro research targeting glucocorticoid signaling, anti-inflammatory mechanisms, and immunosuppression. This product is best suited for controlled laboratory workflows requiring precise modulation of receptor-driven pathways, but it is not intended for diagnostic or clinical use.

• Triamcinolone: Technical Guidance for Glucocorticoid Researc

  2026-07-03

  Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist used in research to model glucocorticoid receptor signaling and anti-inflammatory mechanisms in vitro. This compound helps address the need for reproducible, high-purity reagents in cellular and molecular studies of inflammation and immunosuppression. It is not suitable for diagnostic or clinical use, and requires specific handling for reliable results.

• Optimizing hiPSC Platelet Differentiation: Protocol Advances

  2026-07-02

  This study introduces a systematically optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), significantly increasing yield and reducing costs. Key innovations include strategic modulation of embryoid body input, serum-free media supplementation, and the use of targeted small molecules, advancing scalable platelet production for research and therapeutic applications.

• γH2AX DNA Damage Detection Kit: Illuminating DNA Repair Path

  2026-07-02

  Explore how the γH2AX DNA Damage Detection Kit empowers advanced DNA damage and repair research. This in-depth analysis reveals the molecular mechanisms, best practices, and unique assay optimizations that distinguish this kit for precise detection of DNA double-strand breaks.

• ERAD-Engaging Chimeras Enable Efficient Degradation of TM Pr

  2026-07-01

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that selectively degrades transmembrane proteins by hijacking the ER-associated degradation pathway. This work addresses a central limitation in targeted protein degradation, offering new opportunities for membrane protein research and drug discovery.

• Triamcinolone: Practical Guidance for Glucocorticoid Researc

  2026-07-01

  Triamcinolone is a synthetic glucocorticoid agonist designed for precise modulation of glucocorticoid signaling pathways in cellular and molecular research. Researchers benefit from its high purity and controlled receptor activation, but it is not suitable for diagnostic or clinical use. Proper attention to solubility and storage is essential for consistent results.

• Tioconazole (SKU B2051): Reliable Workflows for Antifungal A

  2026-06-30

  This article addresses key pain points in antifungal research by exploring real-world laboratory scenarios where Tioconazole (SKU B2051) enhances reproducibility and data integrity. With evidence-driven Q&A blocks tailored for biomedical researchers and technicians, we demonstrate how Tioconazole’s high purity, validated solubility, and mechanistic specificity support robust in vitro antifungal drug development and fungal infection models.

• E-64d: Precision Inhibition of Cysteine Proteases in Cell De

  2026-06-30

  E-64d is a synthetic, membrane-permeable cysteine protease inhibitor with high specificity for calpain and cathepsins, enabling precise dissection of regulated cell death pathways. Its irreversible mechanism and cell permeability make it a gold standard for studying apoptosis, lysoptosis, and neuroprotection in preclinical models.

• circRHOBTB3 Regulates NONO/MAOA Axis to Suppress Prostate Ca

  2026-06-29

  This study uncovers a novel tumor suppressor role for circRHOBTB3 in metastatic prostate cancer, demonstrating its ability to inhibit tumor growth and metastasis by regulating the cytoplasmic retention of NONO and suppressing MAOA expression. The findings highlight circRHOBTB3 as a promising biomarker and therapeutic target, offering new avenues for understanding metastatic progression.

450 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page